Phathom Pharmaceuticals Inc
NASDAQ:PHAT

Watchlist Manager
Phathom Pharmaceuticals Inc Logo
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
Watchlist
Price: 9.27 USD -4.92% Market Closed
Market Cap: 552.4m USD
Have any thoughts about
Phathom Pharmaceuticals Inc?
Write Note

EV/EBIT
Enterprise Value to EBIT

-2.5
Current
-4.1
Median
17.2
Industry
Higher than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-2.5
=
Enterprise Value
715.8m USD
/
EBIT
-287.9m USD
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
-2.5
2-Years Forward
EV/EBIT
-3
3-Years Forward
EV/EBIT
-5.4

See Also

Discover More